CA2234511A1 - Pyrazoles 1,3,5-trisubstitues pour le traitement des inflammations - Google Patents

Pyrazoles 1,3,5-trisubstitues pour le traitement des inflammations Download PDF

Info

Publication number
CA2234511A1
CA2234511A1 CA002234511A CA2234511A CA2234511A1 CA 2234511 A1 CA2234511 A1 CA 2234511A1 CA 002234511 A CA002234511 A CA 002234511A CA 2234511 A CA2234511 A CA 2234511A CA 2234511 A1 CA2234511 A1 CA 2234511A1
Authority
CA
Canada
Prior art keywords
compound
salt
formula
phenyl
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002234511A
Other languages
English (en)
Inventor
Keiko Harada
Katsuya Nakamura
Takashi Ogino
Yuka Noda
Kiyoshi Tsuji
Hiroaki Nishimura
Kazuo Okumura
Masaaki Matsuo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2234511A1 publication Critical patent/CA2234511A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16—Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composé de la formule (I). Dans cette formule, R?1¿ est hydroxyéthyle, 1-hydroxy-1-méthyléthyle, hydrogène, halogène, nitro ou cyano; R?2¿ est chloro, cyano, ou alkyle inférieur facultativement substitué par halogène, et R?3¿ est alkylthio inférieur, alkylsulfinyle inférieur, ou alkylsulfonyl inférieur, sous réserve que, lorsque R?1¿ est hydrogène, halogène, nitro ou cyano, R?2¿ est chloro. L'invention porte également sur un sel pharmaceutiquement acceptable de ce composé, sur des procédés conçus pour leur préparation et sur des compositions pharmaceutiquement acceptables.
CA002234511A 1995-10-09 1996-10-08 Pyrazoles 1,3,5-trisubstitues pour le traitement des inflammations Abandoned CA2234511A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9520584.5 1995-10-09
GBGB9520584.5A GB9520584D0 (en) 1995-10-09 1995-10-09 Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same

Publications (1)

Publication Number Publication Date
CA2234511A1 true CA2234511A1 (fr) 1997-04-17

Family

ID=10782007

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002234511A Abandoned CA2234511A1 (fr) 1995-10-09 1996-10-08 Pyrazoles 1,3,5-trisubstitues pour le traitement des inflammations

Country Status (9)

Country Link
EP (1) EP0856000A1 (fr)
JP (1) JPH11513403A (fr)
KR (1) KR19990063989A (fr)
CN (1) CN1203589A (fr)
AU (1) AU7146196A (fr)
CA (1) CA2234511A1 (fr)
GB (1) GB9520584D0 (fr)
WO (1) WO1997013755A1 (fr)
ZA (1) ZA968286B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA68348C2 (en) * 1997-04-18 2004-08-16 Searle & Co Use of cyclooxygenase-2 inhibitors in preventing cardiovascular disorders
US5886191A (en) * 1997-08-18 1999-03-23 Dupont Pharmaceuticals Company Amidinoindoles, amidinoazoles, and analogs thereof
AUPO941497A0 (en) * 1997-09-24 1997-10-16 Fujisawa Pharmaceutical Co., Ltd. Novel compounds
AUPP042397A0 (en) * 1997-11-18 1997-12-11 Fujisawa Pharmaceutical Co., Ltd. 5-arylpyrazole compounds
NZ333399A (en) 1997-12-24 2000-05-26 Sankyo Co Cyclooxygenase-2 inhibitors (COX-2) for the prevention and treatment of tumors, cachexia and tumor-metastasis
ES2137138B1 (es) * 1998-05-29 2000-09-16 Esteve Labor Dr Derivados de pirazolinas, su preparacion y su aplicacion como medicamentos.
US6506747B1 (en) * 1998-06-05 2003-01-14 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents
US6294558B1 (en) 1999-05-31 2001-09-25 Pfizer Inc. Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
US6727238B2 (en) 1998-06-11 2004-04-27 Pfizer Inc. Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
WO2000018741A2 (fr) * 1998-09-30 2000-04-06 Fujisawa Pharmaceutical Co., Ltd. Nouveaux composes
CA2379421A1 (fr) * 1999-08-27 2001-03-08 Abbott Laboratories Composes sulfonylphenylpyrazoles utiles en tant qu'inhibiteurs de cox-2
EP1104759B1 (fr) 1999-12-03 2003-10-22 Pfizer Products Inc. Composés hétéroarylphénylpyrazoles comme agents analgésiques et anti-inflammatoires
BR0016031A (pt) 1999-12-03 2002-07-23 Pfizer Prod Inc Derivados de heterociclo-alquilsulfonil pirazol como agentes antiinflamatórios/analgésicos
EP1104758B1 (fr) 1999-12-03 2003-07-23 Pfizer Products Inc. Dérives acétylènes anti-inflammatoires et/ou analgésiques
ES2193921T3 (es) 1999-12-03 2003-11-16 Pfizer Prod Inc Compuestos de sulfamoilheteroaril-pirazol como agentes antinflamatorios/analgesicos.
EP1273582B1 (fr) 2001-07-05 2005-06-29 Pfizer Products Inc. Pyrazoles heterocycliques alkylsulfoniques comme agents anti-inflammatoires/analgésiques
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
GT200200183A (es) 2001-09-28 2003-05-23 Procedimiento para preparar derivados de heterocicloalquilsulfonil pirazol
WO2003037336A1 (fr) 2001-11-02 2003-05-08 Pfizer Products Inc. Derives de 1-(5-sulfonyl-pyridin-2-yl)-5-(methylidene-cycloalkylmethoxy)-1h-pyrazole-4-carbonitrile et autres composes utilises en tant qu'inhibiteurs de la cyclooxygenase dans le traitement de l'arthrite, de la neurodegeneration et du cancer du colon
AU2003279622A1 (en) 2002-06-28 2004-01-19 Nitromed, Inc. Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use
JP2006511606A (ja) 2002-12-13 2006-04-06 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 下部尿路症状を治療するα−２−δリガンド
ES2257929B1 (es) * 2004-07-16 2007-05-01 Laboratorios Del Dr. Esteve, S.A. Derivados de pirazolina, procedimiento para su obtencion y utilizacion de los mismos como agentes terapeuticos.
RS51940B (en) 2006-12-22 2012-02-29 Recordati Ireland Limited Combined TH2δ LIGANAD THERAPY AND NSAID FOR LOWER URINARY TRACT DISORDERS
JP6151358B2 (ja) * 2012-07-30 2017-06-21 ザ オハイオ ステイト ユニバーシティ 抗菌性プロテインキナーゼインヒビター
IL305573A (en) 2021-03-15 2023-10-01 Saul Yedgar Hyaluronic acid conjugated with dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (NSAIDs) for the treatment or suppression of inflammatory diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
IL104311A (en) * 1992-02-05 1997-07-13 Fujisawa Pharmaceutical Co Pyrazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
NZ336428A (en) * 1993-11-30 2005-02-25 G use of substituted pyrazolyl benzosulphonamides to treat inflammation
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
US5434178A (en) * 1993-11-30 1995-07-18 G.D. Searle & Co. 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation
AU3815495A (en) * 1994-11-08 1996-05-31 Eisai Co. Ltd. Pyrazole derivatives exhibiting anti-inflammatory and analgesic effects

Also Published As

Publication number Publication date
CN1203589A (zh) 1998-12-30
WO1997013755A1 (fr) 1997-04-17
ZA968286B (en) 1997-05-13
GB9520584D0 (en) 1995-12-13
JPH11513403A (ja) 1999-11-16
AU7146196A (en) 1997-04-30
EP0856000A1 (fr) 1998-08-05
KR19990063989A (ko) 1999-07-26

Similar Documents

Publication Publication Date Title
CA2234511A1 (fr) Pyrazoles 1,3,5-trisubstitues pour le traitement des inflammations
US5134142A (en) Pyrazole derivatives, and pharmaceutical composition comprising the same
EP0554829B1 (fr) Dérivés du pyrazole à activité anti-inflammatoire, analgésique et antithrombotique
US4810719A (en) Anti-inflammator 1,n-diarylpyrazol-3-amines
CA2443449C (fr) Derives de pyrazole pour le traitement de vih
US5550147A (en) Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
CA2087260A1 (fr) Alkylsulfonylpyrazoles aryliques substituees comme herbicide
Tsuji et al. Studies on anti-inflammatory agents. IV. Synthesis and pharmacological properties of 1, 5-diarylpyrazoles and related derivatives
FI79103C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 1,4-dihydropyridinderivat.
US5128343A (en) Derivatives of pyrimidinyl-piperazinyl-alkyl azoles with anxiolytic and/or tranquilizing activity
HU217907B (hu) Kinolin- vagy kinazolinszármazékok, eljárás a vegyületek előállítására és a vegyületeket tartalmazó gyógyászati készítmények
EP1442026B1 (fr) Derives de triazole utiles comme inhibiteurs de la cyclooxygenase (cox)
EP0510036B1 (fr) 4,5-diphenyl-imidazoles substitues en position 2
CA2047880A1 (fr) Derives de benzimidazole, leur preparation, et leur application en tant que medicaments
US6316485B1 (en) 1,5-diphenylpyrazole derivatives
WO1999025695A1 (fr) Composes 5-arylpyrazole
Drutkowski et al. Derivatives of arylhydrazonic acids. Part 2: A facile approach to novel 4, 5-dihydro-1H-1, 2, 4-triazoles via cyclization of amidrazones
HU201015B (en) Process for producing pyridine derivatives
AU2004200420A1 (en) Inhibitor of cyclooxygenase
WO2000018741A2 (fr) Nouveaux composes
US4657906A (en) Heterocyclic compounds having inotropic activity
JPH10291982A (ja) 新規複素環化合物
AU750356B2 (en) 1,5-diphenylpyrazole derivatives

Legal Events

Date Code Title Description
FZDE Dead